01024nam--2200349---450-99000053226020331620090408122053.088-8233-171-70053226USA010053226(ALEPH)000053226USA01005322620010629d2001----km-y0itay0103----baitaIT||||||||001yyTenere la contabilitàedizione 2001Daniele BalducciMilanoFAGcopyr.2001652 p.24 cmAziendeTributiContabilitàGuide pratiche657.63BALDUCCI,Daniele279469990000532260203316657.63 BAL 1 (IRA 25 391)9519 E.C.IRA 2500074942BKECOPAOLA4020010629USA01140520020403USA011702PATRY9020040406USA011637RSIAV49020090408USA011220Tenere la contabilità886464UNISA01936nam 2200493 a 450 991069715740332120230902161716.0(CKB)5470000002385337(OCoLC)708361533(EXLCZ)99547000000238533720110324d2010 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierFalse carbamazepine positives due to 10,11-dihydro-10-hydroxycarbamazepine breakdown in the GC/MS injector port[electronic resource] /Robert D. Johnson, Russell J. Lewis, and Mike K. AngierWashington, D.C. :Federal Aviation Administration, Office of Aerospace Medicine,[2010]1 online resource (iii, 5 pages)"February 2010."Title from title screen (viewed on Mar. 23, 2011)."DOT/FAA/AM-10/4.""This work was accomplished under the approved task AM-B-05-TOX-204."--P. i.Includes bibliographical references.Aviation toxicologyResearchForensic toxicologyAircraft accidentsInvestigationAircraft accidentsHuman factorsCarbamazepineResearchAviation toxicologyResearch.Forensic toxicology.Aircraft accidentsInvestigation.Aircraft accidentsHuman factors.CarbamazepineResearch.Johnson Robert D(Robert David),1974-1382527Lewis Russell J1382528Angier Mike K1384636United States.Office of Aerospace Medicine.GPOGPOBOOK9910697157403321False carbamazepine positives due to 10,11-dihydro-10-hydroxycarbamazepine breakdown in the GC3550280UNINA